e-learning
resources
Virtual 2020
Pre-Congress Content
Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidities in unclassifiable interstitial lung disease
C. Hyldgaard (Silkeborg, Denmark), S. Torrisi (Catania, Italy), S. Kronborg-White (Aarhus, Denmark), C. Ganter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark), M. Kreuter (Heidelberg, Germany)
Source:
Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Session:
Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Session type:
E-poster session
Number:
3409
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Hyldgaard (Silkeborg, Denmark), S. Torrisi (Catania, Italy), S. Kronborg-White (Aarhus, Denmark), C. Ganter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark), M. Kreuter (Heidelberg, Germany). Comorbidities in unclassifiable interstitial lung disease. 3409
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Clusters of comorbidities in unclassifiable interstitial lung disease
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Comorbidities in interstitial lung diseases
Source: Eur Respir Rev 2017; 26: 160027
Year: 2017
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013
Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Clubbing in patients with fibrotic interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Emphysema frequency in the cases who have interstitial lung disease diagnosis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Interstitial lung disease associated with polymyositis-dermatomyositis
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept